Accelerate Diagnostics
AXDX
#10564
Rank
A$1.3 M
Marketcap
A$0.05147
Share price
0.00%
Change (1 day)
-97.89%
Change (1 year)

Accelerate Diagnostics (AXDX) - Net assets

Net assets on the balance sheet as of December 2024 : -A$84.83 Million

According to Accelerate Diagnostics's latest financial reports the company has -A$84.83 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Accelerate Diagnostics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-A$29.2 Million-10.78%
2022-12-31$-A$32.72 Million-32.37%
2021-12-31$-A$48.38 Million-40.78%
2020-12-31$-A$81.69 Million675.07%
2019-12-31$-A$10.54 Million-112.94%
2018-12-31$A$81.44 M-46.44%
2017-12-31$A$0.15 B40.84%
2016-12-31$A$0.10 B-40.88%
2015-12-31$A$0.18 B126.45%
2014-12-31$A$80.63 M73.24%
2013-12-31$A$46.54 M
2012-07-31$A$14.14 M223.72%
2011-07-31$A$4.37 M-19.6%
2010-07-31$A$5.43 M15.51%
2009-07-31$A$4.7 M0.58%
2008-07-31$A$4.67 M-18.04%
2007-07-31$A$5.7 M-35.19%
2006-07-31$A$8.8 M-30.83%
2005-07-31$A$12.73 M-24.13%
2004-07-31$A$16.78 M-14.06%
2003-07-31$A$19.53 M-22.72%
2002-07-31$A$25.27 M32.98%
2001-07-31$A$19 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Thermo Fisher Scientific
TMO
A$77.43 B-91,381.23%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
A$12.16 B-14,435.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$38.55 B-45,555.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$10.19 B-12,121.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-A$76.55 Million-9.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
A$3.77 B-4,547.54%๐Ÿ‡บ๐Ÿ‡ธ USA